Franzin Alberto, Snider Silvia, Picozzi Piero, Bolognesi Angelo, Serra Carlo, Vimercati Alberto, Passarin Olga, Mortini Pietro
Department of Neurosurgery and Radiosurgery, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):707-13. doi: 10.1016/j.ijrobp.2008.08.062. Epub 2008 Dec 25.
To assess the utility of the Radiation Therapy Oncology Group Recursive Partitioning Analysis (RPA) and Score Index for Radiosurgery (SIR) stratification systems in predicting survival in patients with brain metastasis treated with Gamma Knife radiosurgery (GKRS).
A total of 185 patients were included in the study. Patients were stratified according to RPA and SIR classes. The RPA and SIR classes, age, Karnofsky Performance Status (KPS), and systemic disease were correlated with survival.
Five patients were lost to follow-up. Median survival in patients in RPA Class 1 (30 patients) was 17 months; in Class 2 (140 patients), 10 months; and in Class 3 (10 patients), 3 months. Median survival in patients in SIR Class 1 (30 patients) was 3 months; in Class 2 (135 patients), 8 months; and in Class 3 (15 patients), 20 months. In univariate testing, age younger than 65 years (p = 0.0004), KPS higher than 70 (p = 0.0001), RPA class (p = 0.0078), SIR class (p = 0.0002), and control of the primary tumor (p = 0.02) were significantly associated with improved outcome. In multivariate analysis, KPS (p < 0.0001), SIR class (p = 0.0008), and RPA class (p = 0.03) had statistical value.
This study supports the use of GKRS as a single-treatment modality in this selected group of patients. Stratification systems are useful in the estimation of patient eligibility for GKRS. A second-line treatment was necessary in 30% of patients to achieve distal or local brain control. This strategy is useful to control brain metastasis in long-surviving patients.
评估放射治疗肿瘤学组递归划分分析(RPA)和立体定向放射外科评分指数(SIR)分层系统在预测接受伽玛刀立体定向放射外科治疗(GKRS)的脑转移瘤患者生存情况中的效用。
本研究共纳入185例患者。患者根据RPA和SIR分级进行分层。RPA和SIR分级、年龄、卡氏功能状态评分(KPS)以及全身疾病与生存情况相关。
5例患者失访。RPA 1级(30例患者)的中位生存期为17个月;2级(140例患者)为10个月;3级(10例患者)为3个月。SIR 1级(30例患者)的中位生存期为3个月;2级(135例患者)为8个月;3级(15例患者)为20个月。在单因素分析中,年龄小于65岁(p = 0.0004)、KPS高于70(p = 0.0001)、RPA分级(p = 0.0078)、SIR分级(p = 0.0002)以及原发肿瘤的控制情况(p = 0.02)与较好的预后显著相关。在多因素分析中,KPS(p < 0.0001)、SIR分级(p = 0.0008)和RPA分级(p = 0.03)具有统计学意义。
本研究支持在这一特定患者群体中使用GKRS作为单一治疗方式。分层系统有助于评估患者接受GKRS治疗的适宜性。30%的患者需要二线治疗以实现脑远处或局部控制。该策略对于控制长期生存患者的脑转移瘤是有用的。